

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.95645873 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.95645873 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.04974305 |
| 4 | negative T cell selection (GO:0043383) | 3.89410732 |
| 5 | negative thymic T cell selection (GO:0045060) | 3.86879779 |
| 6 | behavioral response to nicotine (GO:0035095) | 3.80907343 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80299745 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75335592 |
| 9 | locomotory exploration behavior (GO:0035641) | 3.51732428 |
| 10 | positive regulation of defense response to virus by host (GO:0002230) | 3.50365126 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49832198 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47506432 |
| 13 | positive thymic T cell selection (GO:0045059) | 3.45261410 |
| 14 | positive T cell selection (GO:0043368) | 3.43455508 |
| 15 | cellular response to exogenous dsRNA (GO:0071360) | 3.42637387 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 3.40484798 |
| 17 | synaptic vesicle maturation (GO:0016188) | 3.39543835 |
| 18 | T cell selection (GO:0045058) | 3.34711558 |
| 19 | leukocyte aggregation (GO:0070486) | 3.27399039 |
| 20 | defense response to protozoan (GO:0042832) | 3.26701497 |
| 21 | T cell migration (GO:0072678) | 3.24456728 |
| 22 | thymic T cell selection (GO:0045061) | 3.23631094 |
| 23 | negative regulation of interleukin-6 production (GO:0032715) | 3.22134552 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21975981 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20389056 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.20389056 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20389056 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20389056 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20389056 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.20389056 |
| 31 | response to protozoan (GO:0001562) | 3.16003734 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15665691 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15665691 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 3.14541288 |
| 35 | mast cell activation (GO:0045576) | 3.11657622 |
| 36 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.10801944 |
| 37 | signal complex assembly (GO:0007172) | 3.08970726 |
| 38 | regulation of mast cell activation (GO:0033003) | 3.08553047 |
| 39 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.08536878 |
| 40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08041448 |
| 41 | negative regulation of interleukin-1 production (GO:0032692) | 3.07280930 |
| 42 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.04361425 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.01306701 |
| 44 | response to interleukin-15 (GO:0070672) | 3.01256682 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.00944808 |
| 46 | mast cell degranulation (GO:0043303) | 3.00640117 |
| 47 | mast cell activation involved in immune response (GO:0002279) | 3.00640117 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 2.99865738 |
| 49 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.98793642 |
| 50 | regulation of ARF protein signal transduction (GO:0032012) | 2.98198770 |
| 51 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.94705154 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 2.93992458 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93815467 |
| 54 | response to muramyl dipeptide (GO:0032495) | 2.93365080 |
| 55 | DNA deamination (GO:0045006) | 2.93172445 |
| 56 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.92491818 |
| 57 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92078050 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90773238 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 2.89966250 |
| 60 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.88830044 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.88669765 |
| 62 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.87983476 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 2.87122461 |
| 64 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82985175 |
| 65 | mature B cell differentiation (GO:0002335) | 2.81514129 |
| 66 | L-fucose catabolic process (GO:0042355) | 2.78481747 |
| 67 | fucose catabolic process (GO:0019317) | 2.78481747 |
| 68 | L-fucose metabolic process (GO:0042354) | 2.78481747 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.78124997 |
| 70 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74475270 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.73716530 |
| 72 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.72740830 |
| 73 | response to peptidoglycan (GO:0032494) | 2.71802227 |
| 74 | T cell receptor signaling pathway (GO:0050852) | 2.71636577 |
| 75 | sodium ion export (GO:0071436) | 2.71338482 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 2.70731945 |
| 77 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.70475037 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70298358 |
| 79 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.68947501 |
| 80 | modulation by symbiont of host cellular process (GO:0044068) | 2.68947432 |
| 81 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67749260 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67692043 |
| 83 | tryptophan catabolic process (GO:0006569) | 2.66462628 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 2.66462628 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 2.66462628 |
| 86 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.66320878 |
| 87 | superoxide anion generation (GO:0042554) | 2.65925758 |
| 88 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.65534492 |
| 89 | synaptic vesicle exocytosis (GO:0016079) | 2.64633973 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.64431534 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.64431534 |
| 92 | regulation of B cell differentiation (GO:0045577) | 2.63580001 |
| 93 | negative regulation of mast cell activation (GO:0033004) | 2.62200355 |
| 94 | germinal center formation (GO:0002467) | 2.61772733 |
| 95 | interferon-gamma production (GO:0032609) | 2.61122694 |
| 96 | regulation of mast cell degranulation (GO:0043304) | 2.60673273 |
| 97 | neutrophil activation involved in immune response (GO:0002283) | 2.59687114 |
| 98 | exploration behavior (GO:0035640) | 2.59409358 |
| 99 | activated T cell proliferation (GO:0050798) | 2.58668536 |
| 100 | detection of other organism (GO:0098543) | 2.57595319 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56160217 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55696372 |
| 103 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55226209 |
| 104 | microglial cell activation (GO:0001774) | 2.55002084 |
| 105 | cellular response to interferon-beta (GO:0035458) | 2.54634040 |
| 106 | positive regulation of granulocyte differentiation (GO:0030854) | 2.54039687 |
| 107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.53656335 |
| 108 | positive regulation of protein homooligomerization (GO:0032464) | 2.53132287 |
| 109 | detection of bacterium (GO:0016045) | 2.53125057 |
| 110 | purinergic receptor signaling pathway (GO:0035587) | 2.52434140 |
| 111 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.52104097 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 2.51423461 |
| 113 | regulation of defense response to virus by host (GO:0050691) | 2.51310954 |
| 114 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50973360 |
| 115 | B cell homeostasis (GO:0001782) | 2.49896418 |
| 116 | positive regulation of B cell differentiation (GO:0045579) | 2.49587399 |
| 117 | regulation of Rap GTPase activity (GO:0032317) | 2.49083767 |
| 118 | regulation of synapse structural plasticity (GO:0051823) | 2.48945727 |
| 119 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.48632708 |
| 120 | positive regulation of Rap GTPase activity (GO:0032854) | 2.48490226 |
| 121 | tolerance induction (GO:0002507) | 2.48183165 |
| 122 | positive regulation of histone deacetylation (GO:0031065) | 2.47352759 |
| 123 | regulation of interferon-alpha production (GO:0032647) | 2.47203405 |
| 124 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.47193892 |
| 125 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.46369364 |
| 126 | autophagic vacuole fusion (GO:0000046) | 2.46284261 |
| 127 | regulation of ARF GTPase activity (GO:0032312) | 2.46044466 |
| 128 | kynurenine metabolic process (GO:0070189) | 2.45874143 |
| 129 | negative regulation of T cell mediated immunity (GO:0002710) | 2.45264266 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 2.45200699 |
| 131 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.44626859 |
| 132 | leukocyte degranulation (GO:0043299) | 2.44443253 |
| 133 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.42506312 |
| 134 | positive regulation of fibroblast migration (GO:0010763) | 2.42202606 |
| 135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.41757611 |
| 136 | response to host immune response (GO:0052572) | 2.41719868 |
| 137 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41719868 |
| 138 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.41109023 |
| 139 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.40735109 |
| 140 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.40625432 |
| 141 | neutrophil activation (GO:0042119) | 2.40578483 |
| 142 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.39886834 |
| 143 | vocalization behavior (GO:0071625) | 2.39694970 |
| 144 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.39194064 |
| 145 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.39127982 |
| 146 | response to type I interferon (GO:0034340) | 2.36587725 |
| 147 | granulocyte activation (GO:0036230) | 2.36356632 |
| 148 | lymphocyte migration (GO:0072676) | 2.36328874 |
| 149 | cellular extravasation (GO:0045123) | 2.34983479 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.34439682 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.34439682 |
| 152 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.33950963 |
| 153 | response to host (GO:0075136) | 2.33950963 |
| 154 | response to host defenses (GO:0052200) | 2.33950963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.36562416 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88133243 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.34758190 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.21988207 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.96786499 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80856577 |
| 7 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.73321669 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60895085 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.58138056 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57260233 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54276419 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52655457 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42137604 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39400523 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34086127 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31486068 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29780674 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24446896 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.18479753 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16268071 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13679420 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09023611 |
| 23 | * MYC_22102868_ChIP-Seq_BL_Human | 2.08211166 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04170052 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96471815 |
| 26 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.96128260 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92166328 |
| 28 | * MYB_26560356_Chip-Seq_TH2_Human | 1.91483438 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.91400206 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.88746560 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86751217 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83477876 |
| 33 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82575363 |
| 34 | * MAF_26560356_Chip-Seq_TH1_Human | 1.78738632 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77241427 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76001475 |
| 37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.74994106 |
| 38 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72814220 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70709235 |
| 40 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.65904983 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65768984 |
| 42 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64742785 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62858795 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61195791 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59994586 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59906868 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56157060 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53989691 |
| 49 | * MYB_26560356_Chip-Seq_TH1_Human | 1.50036586 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47142849 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46707453 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46159986 |
| 53 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.43744133 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43645719 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42645675 |
| 56 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42329062 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40169757 |
| 58 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38665351 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37577122 |
| 60 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37496297 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36972663 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35621948 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29878834 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.29304463 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.29111619 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27395460 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26530680 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24715389 |
| 69 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.24518601 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24207825 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23230848 |
| 72 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23187250 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22069328 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21371760 |
| 75 | ERA_21632823_ChIP-Seq_H3396_Human | 1.20173740 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19865313 |
| 77 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19415769 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18520498 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 1.18017741 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14792549 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14600290 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.13985162 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13533687 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12185443 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10573744 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10467550 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10382831 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.09942231 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09834084 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09721845 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09007913 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08489858 |
| 93 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07988986 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06960409 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.06706081 |
| 96 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06552950 |
| 97 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06287230 |
| 98 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06287230 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06264009 |
| 100 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05275470 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03463361 |
| 102 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.99826876 |
| 103 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99079886 |
| 104 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98866866 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97383899 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97332655 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97132778 |
| 108 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97047966 |
| 109 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.96407982 |
| 110 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96067764 |
| 111 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95987260 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95639823 |
| 113 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95525421 |
| 114 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95164000 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93594122 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92744009 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92286168 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90408979 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90314343 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90314343 |
| 121 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.90155180 |
| 122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89670407 |
| 123 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89136575 |
| 124 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88953301 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88868314 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88128899 |
| 127 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87941121 |
| 128 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87835047 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87237494 |
| 130 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87126468 |
| 131 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86234383 |
| 132 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85880506 |
| 133 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.85815876 |
| 134 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85712863 |
| 135 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85581679 |
| 136 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85102675 |
| 137 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84553507 |
| 138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84202793 |
| 139 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84146633 |
| 140 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.83372849 |
| 141 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82763284 |
| 142 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82642648 |
| 143 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.82339692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.98162682 |
| 2 | MP0004510_myositis | 2.98260947 |
| 3 | MP0003303_peritoneal_inflammation | 2.97625421 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.88294841 |
| 5 | MP0000685_abnormal_immune_system | 2.61886650 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.55563631 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.54094588 |
| 8 | MP0003436_decreased_susceptibility_to | 2.46769066 |
| 9 | MP0005387_immune_system_phenotype | 2.42723899 |
| 10 | MP0001790_abnormal_immune_system | 2.42723899 |
| 11 | MP0001800_abnormal_humoral_immune | 2.41814425 |
| 12 | MP0005671_abnormal_response_to | 2.39310012 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.35177188 |
| 14 | MP0003880_abnormal_central_pattern | 2.30793222 |
| 15 | MP0002723_abnormal_immune_serum | 2.23159288 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.22156130 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.19139347 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.18533687 |
| 19 | MP0001819_abnormal_immune_cell | 2.18150697 |
| 20 | MP0002419_abnormal_innate_immunity | 2.14646026 |
| 21 | MP0009785_altered_susceptibility_to | 2.09888982 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.07525995 |
| 23 | MP0005025_abnormal_response_to | 2.01665874 |
| 24 | MP0001986_abnormal_taste_sensitivity | 2.00190522 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.99559390 |
| 26 | MP0009278_abnormal_bone_marrow | 1.96779116 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.95489440 |
| 28 | MP0002398_abnormal_bone_marrow | 1.87579280 |
| 29 | MP0009745_abnormal_behavioral_response | 1.86034580 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.85672457 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.83426170 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.79287021 |
| 33 | MP0004947_skin_inflammation | 1.76459700 |
| 34 | MP0009764_decreased_sensitivity_to | 1.74173469 |
| 35 | MP0002064_seizures | 1.71829332 |
| 36 | MP0000716_abnormal_immune_system | 1.70252875 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.69358373 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.68342868 |
| 39 | MP0003075_altered_response_to | 1.62366880 |
| 40 | MP0005310_abnormal_salivary_gland | 1.58706999 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.56826339 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.55000449 |
| 43 | MP0002006_tumorigenesis | 1.53447420 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.53419488 |
| 45 | MP0006082_CNS_inflammation | 1.52414228 |
| 46 | MP0002405_respiratory_system_inflammati | 1.52230723 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.46393377 |
| 48 | MP0004043_abnormal_pH_regulation | 1.46267551 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.45661311 |
| 50 | MP0003646_muscle_fatigue | 1.41824401 |
| 51 | MP0004130_abnormal_muscle_cell | 1.40927275 |
| 52 | MP0004270_analgesia | 1.39554581 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.38825218 |
| 54 | MP0001663_abnormal_digestive_system | 1.38113816 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.34141707 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.34141707 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.33834965 |
| 58 | MP0001873_stomach_inflammation | 1.33093966 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.32560832 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.32417745 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.32203810 |
| 62 | MP0002722_abnormal_immune_system | 1.31705123 |
| 63 | MP0008569_lethality_at_weaning | 1.31304934 |
| 64 | MP0004858_abnormal_nervous_system | 1.30768466 |
| 65 | MP0002429_abnormal_blood_cell | 1.29848682 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.28331681 |
| 67 | MP0009046_muscle_twitch | 1.27946851 |
| 68 | MP0003195_calcinosis | 1.27670210 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.27251265 |
| 70 | MP0000604_amyloidosis | 1.24719560 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.23814750 |
| 72 | MP0002736_abnormal_nociception_after | 1.23564464 |
| 73 | MP0002928_abnormal_bile_duct | 1.22422495 |
| 74 | MP0004142_abnormal_muscle_tone | 1.21122011 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.20887547 |
| 76 | MP0004811_abnormal_neuron_physiology | 1.13612315 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.12310449 |
| 78 | MP0004381_abnormal_hair_follicle | 1.11548303 |
| 79 | MP0005423_abnormal_somatic_nervous | 1.11098263 |
| 80 | MP0001970_abnormal_pain_threshold | 1.09203097 |
| 81 | MP0002822_catalepsy | 1.08249591 |
| 82 | MP0002693_abnormal_pancreas_physiology | 1.08152350 |
| 83 | MP0008874_decreased_physiological_sensi | 1.07997903 |
| 84 | MP0003724_increased_susceptibility_to | 1.06461049 |
| 85 | MP0008872_abnormal_physiological_respon | 1.04796475 |
| 86 | MP0001853_heart_inflammation | 1.04386653 |
| 87 | MP0005166_decreased_susceptibility_to | 1.03778002 |
| 88 | MP0002933_joint_inflammation | 1.03664720 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.03027493 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 1.02889808 |
| 91 | MP0003866_abnormal_defecation | 1.02456008 |
| 92 | MP0003633_abnormal_nervous_system | 1.00684580 |
| 93 | MP0002272_abnormal_nervous_system | 1.00561404 |
| 94 | MP0002733_abnormal_thermal_nociception | 1.00320725 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.99501986 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.99083609 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.98971466 |
| 98 | MP0003091_abnormal_cell_migration | 0.96939223 |
| 99 | MP0001486_abnormal_startle_reflex | 0.95277953 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.94691788 |
| 101 | MP0003448_altered_tumor_morphology | 0.93177332 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.93025253 |
| 103 | MP0003787_abnormal_imprinting | 0.92740304 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.92711046 |
| 105 | MP0003329_amyloid_beta_deposits | 0.90618302 |
| 106 | MP0003045_fibrosis | 0.88710522 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.84381065 |
| 108 | MP0000858_altered_metastatic_potential | 0.83389142 |
| 109 | MP0008469_abnormal_protein_level | 0.82673659 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.81487103 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.81413218 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.81136224 |
| 113 | MP0005551_abnormal_eye_electrophysiolog | 0.81110761 |
| 114 | MP0004742_abnormal_vestibular_system | 0.79340023 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.79275585 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.79248877 |
| 117 | MP0008004_abnormal_stomach_pH | 0.76135334 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.75832614 |
| 119 | MP0003879_abnormal_hair_cell | 0.75645215 |
| 120 | MP0001851_eye_inflammation | 0.75422847 |
| 121 | MP0005448_abnormal_energy_balance | 0.72588282 |
| 122 | MP0008877_abnormal_DNA_methylation | 0.71660871 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.71200865 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.71039974 |
| 125 | MP0005390_skeleton_phenotype | 0.70198518 |
| 126 | MP0003631_nervous_system_phenotype | 0.68031631 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.67080455 |
| 128 | MP0004885_abnormal_endolymph | 0.65812339 |
| 129 | MP0002184_abnormal_innervation | 0.64934050 |
| 130 | MP0002168_other_aberrant_phenotype | 0.63849449 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.62398248 |
| 132 | MP0002095_abnormal_skin_pigmentation | 0.61430742 |
| 133 | MP0000371_diluted_coat_color | 0.60975949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42713927 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.34563594 |
| 3 | Stomatitis (HP:0010280) | 4.22695688 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.93912919 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.88887392 |
| 6 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.79077434 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.59496103 |
| 8 | Recurrent viral infections (HP:0004429) | 3.47072208 |
| 9 | Focal motor seizures (HP:0011153) | 3.42438946 |
| 10 | Myokymia (HP:0002411) | 3.34095898 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.33309528 |
| 12 | Myositis (HP:0100614) | 3.33081952 |
| 13 | Chronic otitis media (HP:0000389) | 3.32902538 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.26186090 |
| 15 | Pancreatic cysts (HP:0001737) | 3.18006668 |
| 16 | Visual hallucinations (HP:0002367) | 3.12586919 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.04620278 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.04620278 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.04310693 |
| 20 | Clumsiness (HP:0002312) | 3.04278242 |
| 21 | T lymphocytopenia (HP:0005403) | 3.02976734 |
| 22 | Agammaglobulinemia (HP:0004432) | 2.99615996 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98603529 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98603529 |
| 25 | Hyperventilation (HP:0002883) | 2.97538181 |
| 26 | Focal seizures (HP:0007359) | 2.96058127 |
| 27 | Genetic anticipation (HP:0003743) | 2.95266765 |
| 28 | Cellulitis (HP:0100658) | 2.92971872 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.88218654 |
| 30 | Optic neuritis (HP:0100653) | 2.88218654 |
| 31 | Protruding tongue (HP:0010808) | 2.85986484 |
| 32 | Encephalitis (HP:0002383) | 2.85350356 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81170435 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 2.80971784 |
| 35 | Recurrent skin infections (HP:0001581) | 2.75433858 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67323353 |
| 37 | Obstructive lung disease (HP:0006536) | 2.67323353 |
| 38 | Meningitis (HP:0001287) | 2.65456239 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.62486787 |
| 40 | Attenuation of retinal blood vessels (HP:0007843) | 2.62118023 |
| 41 | Orchitis (HP:0100796) | 2.61877363 |
| 42 | Vasculitis (HP:0002633) | 2.61274514 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.56587033 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.56008209 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.54969282 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.54480938 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.51318976 |
| 48 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.51148825 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.51148825 |
| 50 | Gingivitis (HP:0000230) | 2.50890468 |
| 51 | Pustule (HP:0200039) | 2.49561675 |
| 52 | Papilledema (HP:0001085) | 2.48770455 |
| 53 | Nephronophthisis (HP:0000090) | 2.48736377 |
| 54 | Polydipsia (HP:0001959) | 2.46521672 |
| 55 | Abnormal drinking behavior (HP:0030082) | 2.46521672 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.44390816 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41136104 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.39498426 |
| 59 | Febrile seizures (HP:0002373) | 2.38696034 |
| 60 | Thyroiditis (HP:0100646) | 2.38181687 |
| 61 | Leukocytosis (HP:0001974) | 2.38088821 |
| 62 | Recurrent sinusitis (HP:0011108) | 2.34758172 |
| 63 | Truncal ataxia (HP:0002078) | 2.32232367 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31922178 |
| 65 | Hypochromic anemia (HP:0001931) | 2.31908645 |
| 66 | True hermaphroditism (HP:0010459) | 2.31538507 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.30621034 |
| 68 | Decreased circulating renin level (HP:0003351) | 2.26973094 |
| 69 | Nasal polyposis (HP:0100582) | 2.26721115 |
| 70 | Colitis (HP:0002583) | 2.26181803 |
| 71 | Abnormality of T cells (HP:0002843) | 2.25711760 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.25422045 |
| 73 | Stomach cancer (HP:0012126) | 2.24714810 |
| 74 | Large for gestational age (HP:0001520) | 2.24188300 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.22038434 |
| 76 | Inability to walk (HP:0002540) | 2.21119737 |
| 77 | Verrucae (HP:0200043) | 2.21113390 |
| 78 | Papilloma (HP:0012740) | 2.21113390 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.19464950 |
| 80 | Progressive cerebellar ataxia (HP:0002073) | 2.19012936 |
| 81 | Eosinophilia (HP:0001880) | 2.17137305 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.16499055 |
| 83 | Absence seizures (HP:0002121) | 2.16095473 |
| 84 | Atonic seizures (HP:0010819) | 2.15151304 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13291402 |
| 86 | Ocular albinism (HP:0001107) | 2.13008959 |
| 87 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12891733 |
| 88 | Periodontitis (HP:0000704) | 2.12785477 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.10869911 |
| 90 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10570824 |
| 91 | Severe combined immunodeficiency (HP:0004430) | 2.10565839 |
| 92 | Chronic sinusitis (HP:0011109) | 2.10158393 |
| 93 | Abnormality of binocular vision (HP:0011514) | 2.09361163 |
| 94 | Diplopia (HP:0000651) | 2.09361163 |
| 95 | IgM deficiency (HP:0002850) | 2.09276684 |
| 96 | Loss of speech (HP:0002371) | 2.09208801 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.07921351 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 2.07744240 |
| 99 | Increased IgE level (HP:0003212) | 2.07501904 |
| 100 | Absent frontal sinuses (HP:0002688) | 2.07144443 |
| 101 | Frequent falls (HP:0002359) | 2.03197550 |
| 102 | Petechiae (HP:0000967) | 2.02862291 |
| 103 | Mutism (HP:0002300) | 2.02194911 |
| 104 | Cystic liver disease (HP:0006706) | 2.01175796 |
| 105 | Action tremor (HP:0002345) | 2.00951920 |
| 106 | Dialeptic seizures (HP:0011146) | 2.00590194 |
| 107 | Spinal canal stenosis (HP:0003416) | 2.00340741 |
| 108 | Abnormal platelet function (HP:0011869) | 2.00247371 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.00247371 |
| 110 | Lymphopenia (HP:0001888) | 1.99691188 |
| 111 | Patellar aplasia (HP:0006443) | 1.99417305 |
| 112 | Arterial thrombosis (HP:0004420) | 1.97553788 |
| 113 | Epileptic encephalopathy (HP:0200134) | 1.97197695 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96237858 |
| 115 | Type II lissencephaly (HP:0007260) | 1.95475066 |
| 116 | Tubular atrophy (HP:0000092) | 1.92881721 |
| 117 | Decreased central vision (HP:0007663) | 1.92822815 |
| 118 | Epistaxis (HP:0000421) | 1.91892171 |
| 119 | Chronic hepatic failure (HP:0100626) | 1.91345944 |
| 120 | Iris hypopigmentation (HP:0007730) | 1.91002836 |
| 121 | Pointed chin (HP:0000307) | 1.90903876 |
| 122 | Global brain atrophy (HP:0002283) | 1.90764497 |
| 123 | Abnormality of eosinophils (HP:0001879) | 1.89546038 |
| 124 | Abnormality of the fingertips (HP:0001211) | 1.88765950 |
| 125 | Hemiplegia (HP:0002301) | 1.88748411 |
| 126 | Inappropriate behavior (HP:0000719) | 1.87784959 |
| 127 | Albinism (HP:0001022) | 1.87427866 |
| 128 | Apathy (HP:0000741) | 1.87061436 |
| 129 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.87010755 |
| 130 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.87010755 |
| 131 | Abnormality of the nasal mucosa (HP:0000433) | 1.85369653 |
| 132 | Hemoptysis (HP:0002105) | 1.84671415 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.84135317 |
| 134 | Impaired smooth pursuit (HP:0007772) | 1.83824477 |
| 135 | Interstitial pulmonary disease (HP:0006530) | 1.83809576 |
| 136 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.83536459 |
| 137 | IgG deficiency (HP:0004315) | 1.83377830 |
| 138 | Abnormality of the renal cortex (HP:0011035) | 1.82292051 |
| 139 | Combined immunodeficiency (HP:0005387) | 1.82048259 |
| 140 | Episodic fever (HP:0001954) | 1.81838434 |
| 141 | B lymphocytopenia (HP:0010976) | 1.81529283 |
| 142 | Abnormality of B cell number (HP:0010975) | 1.81529283 |
| 143 | Granulocytopenia (HP:0001913) | 1.81279469 |
| 144 | Stereotypic behavior (HP:0000733) | 1.81250352 |
| 145 | Diminished motivation (HP:0000745) | 1.80330107 |
| 146 | Progressive inability to walk (HP:0002505) | 1.80177016 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.78399557 |
| 148 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77651487 |
| 149 | Gaze-evoked nystagmus (HP:0000640) | 1.77318226 |
| 150 | Macroglossia (HP:0000158) | 1.77142832 |
| 151 | Abnormality of the pleura (HP:0002103) | 1.76290256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 4.31061899 |
| 2 | FRK | 4.18339418 |
| 3 | RIPK4 | 3.72512214 |
| 4 | MAP4K1 | 3.30052769 |
| 5 | NTRK3 | 2.86427881 |
| 6 | MAP3K14 | 2.62845829 |
| 7 | ADRBK2 | 2.56949208 |
| 8 | TLK1 | 2.47957636 |
| 9 | ACVR1B | 2.46362388 |
| 10 | MAP3K9 | 2.42119947 |
| 11 | SIK2 | 2.41224953 |
| 12 | FES | 2.37521987 |
| 13 | TXK | 2.35269954 |
| 14 | ERN1 | 2.03561349 |
| 15 | IKBKE | 1.98769164 |
| 16 | EPHA4 | 1.92716485 |
| 17 | BMPR1B | 1.87329633 |
| 18 | KSR2 | 1.84224315 |
| 19 | MAP3K11 | 1.82370630 |
| 20 | TBK1 | 1.80188062 |
| 21 | TYK2 | 1.75206422 |
| 22 | JAK1 | 1.68246179 |
| 23 | DAPK2 | 1.66545036 |
| 24 | IRAK4 | 1.61488454 |
| 25 | SYK | 1.61112137 |
| 26 | GRK6 | 1.59197317 |
| 27 | HCK | 1.53135557 |
| 28 | MAP2K3 | 1.50926385 |
| 29 | JAK3 | 1.50396759 |
| 30 | CAMKK1 | 1.48568906 |
| 31 | MAP3K12 | 1.45743387 |
| 32 | ZAP70 | 1.38567760 |
| 33 | IRAK1 | 1.36570441 |
| 34 | BLK | 1.29247482 |
| 35 | PRKCH | 1.28345431 |
| 36 | MAP3K10 | 1.25234708 |
| 37 | IRAK3 | 1.22584564 |
| 38 | DAPK1 | 1.22459024 |
| 39 | ITK | 1.22385334 |
| 40 | GRK1 | 1.21453522 |
| 41 | MAP3K7 | 1.20324599 |
| 42 | ADRBK1 | 1.19946508 |
| 43 | KIT | 1.19720169 |
| 44 | NTRK2 | 1.19447742 |
| 45 | MAPK15 | 1.12967363 |
| 46 | INSRR | 1.12639312 |
| 47 | RAF1 | 1.11283154 |
| 48 | MINK1 | 1.10192971 |
| 49 | PRPF4B | 1.10111798 |
| 50 | LCK | 1.08956818 |
| 51 | TAOK1 | 1.05885220 |
| 52 | IKBKB | 1.02869387 |
| 53 | EEF2K | 1.00898518 |
| 54 | CSK | 1.00666229 |
| 55 | PAK6 | 0.99145315 |
| 56 | CSF1R | 0.98618547 |
| 57 | TRIB3 | 0.98552631 |
| 58 | MAP2K6 | 0.97100568 |
| 59 | PDK1 | 0.96332702 |
| 60 | BTK | 0.95177516 |
| 61 | RPS6KA6 | 0.93873088 |
| 62 | SCYL2 | 0.93133384 |
| 63 | MAPK13 | 0.90711175 |
| 64 | CDC42BPA | 0.86239487 |
| 65 | PKN2 | 0.86129915 |
| 66 | CLK1 | 0.85921863 |
| 67 | MAP3K2 | 0.85149549 |
| 68 | ALK | 0.84707668 |
| 69 | MARK2 | 0.82724138 |
| 70 | JAK2 | 0.82664933 |
| 71 | CDK5 | 0.81586052 |
| 72 | KSR1 | 0.79865827 |
| 73 | MAPK12 | 0.79836615 |
| 74 | PRKCQ | 0.79469041 |
| 75 | ZAK | 0.78844996 |
| 76 | TNK2 | 0.77991708 |
| 77 | CAMKK2 | 0.76884987 |
| 78 | TGFBR1 | 0.76136936 |
| 79 | FGR | 0.73807471 |
| 80 | FGFR3 | 0.73193490 |
| 81 | EPHA3 | 0.73175566 |
| 82 | PTK2B | 0.72966335 |
| 83 | SIK3 | 0.72058419 |
| 84 | FYN | 0.71980700 |
| 85 | STK38 | 0.71336682 |
| 86 | RET | 0.70115544 |
| 87 | LYN | 0.68938682 |
| 88 | WNK4 | 0.67540577 |
| 89 | TEC | 0.65758294 |
| 90 | STK10 | 0.65096844 |
| 91 | IRAK2 | 0.64088590 |
| 92 | TYRO3 | 0.63758624 |
| 93 | MAP3K4 | 0.63151243 |
| 94 | MAP2K2 | 0.62704279 |
| 95 | EPHB1 | 0.62676254 |
| 96 | MAPK11 | 0.62616295 |
| 97 | MAP3K1 | 0.62301461 |
| 98 | CAMK1 | 0.60844019 |
| 99 | NLK | 0.60106215 |
| 100 | CHUK | 0.58276064 |
| 101 | MAPKAPK3 | 0.57260989 |
| 102 | PKN1 | 0.56883056 |
| 103 | STK11 | 0.56121464 |
| 104 | FGFR4 | 0.55875279 |
| 105 | RIPK1 | 0.54895697 |
| 106 | MARK1 | 0.54436407 |
| 107 | SGK1 | 0.54202138 |
| 108 | PRKD2 | 0.53787575 |
| 109 | PDPK1 | 0.53242478 |
| 110 | CAMK1D | 0.53184312 |
| 111 | PIK3CG | 0.52220990 |
| 112 | PINK1 | 0.51536268 |
| 113 | NTRK1 | 0.50459821 |
| 114 | PRKD3 | 0.49450135 |
| 115 | SGK3 | 0.49262438 |
| 116 | TAOK3 | 0.49201709 |
| 117 | ARAF | 0.48809759 |
| 118 | PDGFRB | 0.48543999 |
| 119 | PIM1 | 0.47832244 |
| 120 | MARK3 | 0.47731046 |
| 121 | CDK19 | 0.47619734 |
| 122 | RPS6KL1 | 0.47106092 |
| 123 | RPS6KC1 | 0.47106092 |
| 124 | NUAK1 | 0.47062799 |
| 125 | TGFBR2 | 0.46755486 |
| 126 | CAMK1G | 0.46202898 |
| 127 | RPS6KA2 | 0.46142254 |
| 128 | PTK6 | 0.44493827 |
| 129 | DMPK | 0.44169009 |
| 130 | TRPM7 | 0.43719466 |
| 131 | HIPK2 | 0.43273128 |
| 132 | MAPK4 | 0.41666992 |
| 133 | MATK | 0.41448946 |
| 134 | GRK5 | 0.40803095 |
| 135 | PRKCZ | 0.40571902 |
| 136 | MAPK7 | 0.40550109 |
| 137 | DAPK3 | 0.38212719 |
| 138 | MAP2K7 | 0.38062625 |
| 139 | TNIK | 0.37518310 |
| 140 | MELK | 0.37136397 |
| 141 | MAP3K3 | 0.34820424 |
| 142 | TIE1 | 0.32540924 |
| 143 | MAP2K4 | 0.31951649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17171120 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95044229 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85412460 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83531401 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82281210 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.81507771 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80696296 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.74957269 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68823738 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.66222954 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61709071 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.44700302 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41485741 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.40475727 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39883062 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38477846 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37864565 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.35248821 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34537230 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34233311 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.33631880 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28127618 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26943655 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.26831967 |
| 25 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.25902160 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.25454977 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.25062404 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23466231 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23236546 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20382101 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20378480 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.18795368 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16737377 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16647626 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16617424 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.16393626 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16217928 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.16051748 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16027428 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15636560 |
| 41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.15492507 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10553010 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.09770663 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07975741 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.07639565 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07376167 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06757475 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.06615399 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.06577831 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06249795 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.05787056 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04880284 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04681970 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04370665 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01560146 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 1.01279460 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99783400 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99775034 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97894974 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97552284 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97458298 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.96728056 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95295103 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.95018380 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94786930 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94571634 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93922461 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.93125971 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.92886409 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.92749246 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92252893 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91233421 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90369230 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89906356 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89734104 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88599369 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88181490 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87942787 |
| 79 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87124140 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.86345674 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.84854655 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84507529 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.83378789 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81413055 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81253458 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80436262 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79970532 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79766226 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79146087 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79058540 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78642261 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78516853 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78207960 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78078002 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78015686 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.77222776 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77102159 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76921322 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76417878 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76319932 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76120237 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76101727 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74503982 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.73511020 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73047052 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72158934 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.71928653 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70552553 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.69493284 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69313629 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69269265 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67701705 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.67184112 |
| 114 | Asthma_Homo sapiens_hsa05310 | 0.66721502 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.64300477 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63305874 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62990570 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61042869 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60802521 |
| 120 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60733490 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60614640 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60037038 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.59806264 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58814971 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56676888 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.55067922 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54475764 |
| 128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52969800 |
| 129 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52582717 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51901197 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51692662 |
| 132 | Homologous recombination_Homo sapiens_hsa03440 | 0.48075623 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46156296 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44337191 |

